Incyte Corp (NAS:INCY)
$ 57.26 0.21 (0.37%) Market Cap: 12.88 Bil Enterprise Value: 9.06 Bil PE Ratio: 17.35 PB Ratio: 2.38 GF Score: 86/100

Incyte Corp at Credit Suisse Healthcare Conference - Scottsdale Transcript

Nov 12, 2019 / 03:35PM GMT
Release Date Price: $86.14 (+1.51%)
Evan David Seigerman;dit Suisse AG
CrÃ;Research Division - VP & Senior Equity Research Analyst

© -

Hi, there. My name is Evan Seigerman, and I'm the senior large-cap biotechnology analyst here at Crédit Suisse. And it is my pleasure to welcome Incyte to the first day of our 2019 Healthcare Conference.

And from Incyte, we have Christiana Stamoulis, EVP and CFO; and Steve Stein, EVP and the Chief Medical Officer. Welcome to Scottsdale. Thank you for coming.

Christiana Stamoulis
Incyte Corporation - Executive VP & CFO

Thank you for having us.

Steven H. Stein
Incyte Corporation - Executive VP & Chief Medical Officer

Thank you.

Questions & Answers

Evan David Seigerman;dit Suisse AG
CrÃ;Research Division - VP & Senior Equity Research Analyst

© -

So just before we -- on a high level, can you give us an update as to where Incyte is? I know that there's been a lot of progress going on from

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot